This inventor holds 3 USPTO granted patents. Top assignees: Zetesis S.p.a., Rakepoll Holding B.v.. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: Alberto Panerai: Innovator in Medical Treatments
Introduction
Alberto Panerai is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical treatments, particularly in addressing serious health conditions. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
One of Panerai's latest patents is a method of treatment for amyotrophic lateral sclerosis (ALS) using a protein extractable from mammalian organs. This innovative approach involves administering an effective amount of a 14 kDa protein, particularly from mammalian liver, to patients affected by ALS. Another significant patent focuses on the use of proteins as anti-diabetes agents. This patent describes the extraction of proteins with perchloric acid from animal organs for the preparation of medicaments that are active against autoimmune diseases, including atherosclerosis, arthritis, multiple sclerosis, and diabetes.
Career Highlights
Throughout his career, Panerai has worked with various companies, including Zetesis S.p.a. and Rakepoll Holding B.v. His expertise in medical research and innovation has positioned him as a key figure in the development of new treatment methodologies.
Collaborations
Panerai has collaborated with notable professionals in his field, including Alberto Bartorelli and Pier Luigi Meroni. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Alberto Panerai's contributions to medical innovation, particularly in the treatment of ALS and diabetes, highlight his role as a significant inventor. His work continues to pave the way for new therapeutic approaches that could benefit many patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile